Search
Filter Results
Displaying 231–240 of 661 for “retinal diseases”
-
Dec 20, 2012
Curing Blindness, Part 2: Dick’s Story
Beacon StoriesStem-cell-based therapies – including those derived from a patient’s blood or skin – are among the many cutting-edge approaches to treatments the Foundation has funded for decades.
-
Dec 18, 2012
Curing Blindness, Part 1: Corey’s Story
Beacon StoriesHow gene therapy restored some of a boy’s sight.
-
Sep 22, 2025
A Family United: Thomas’ Hero’s Journey with CRB1
Beacon StoriesWhen Becky’s son Thomas was diagnosed with a rare CRB1-associated disease, their family’s world changed. But today, Becky and Thomas are embracing advocacy, community, and research as they work to raise awareness and fuel progress toward treatments and cures.
-
Jun 24, 2025
Advocacy Research NewsIn this in-depth interview hosted by InVivo, Jason Menzo, CEO of the Foundation Fighting Blindness, outlines the organization’s strategy for addressing significant changes and opportunities in the inherited retinal diseases (IRDs).
-
Dec 16, 2024
Research NewsThe company has also launched a natural history study of patients to inform the planned clinical trial.
-
Jul 28, 2023
Belite Bio Doses First Patient in Phase 3 Clinical Trial for Advanced Dry AMD (GA) Therapy
Research NewsThe company’s emerging, oral treatment is designed to slow vision loss
-
May 21, 2021
New Bipartisan Legislation Introduced to Boost Clinical Research for Treatments and Cures
Research NewsThe bill would provide loans to therapy developers ready to launch clinical trials for a broad range of conditions including eye diseases.
-
Lulie's Next Chapter for Light & Vision
Our vision is to recruit and retain a high performing and well-structured community-based grassroots Chapter leadership and membership. This focus will center around education, resources, and revenue throughout the community.
-
Jan 13, 2021
ProQR Completes Enrollment in Phase 2/3 Clinical Trial of RNA Therapy for LCA10
Research NewsCompany also announced progress in enrollment for Phase 1 / 2 clinical trials for emerging USH2A and RHO RNA therapies.
-
May 27, 2020
Lulie Gund: Beloved Philanthropist, Role Model and Confidant
Beacon StoriesLlura Gund, often referred to as Lulie, was known for her infectious kind smile and love of life.